Back to User profile » Dr Mohamed Ismail
Paper published by Dr Mohamed Ismail:
Original Research
Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)
Azim HA, Omar A, Atef H, Zawahry H, Shaker MK, Abdelmaksoud AHK, EzzElarab M, Abdel-Rahman O, Ismail M, Kassem L, Waked I
Journal of Hepatocellular Carcinoma 2018, 5:109-119
Published Date: 19 November 2018